NCT04067609View on ClinicalTrials.gov

Postoperative Dexamethasone on Post-Cesarean Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Post-Cesarean PainCesarean Section Complications
Interventions
DRUG

Dexamethasone

subjects will receive a single administration of either 0.1 mg/kg of intravenous dexamethasone in 90mL of normal saline

OTHER

placebo

100mL of normal saline (placebo)

Trial Locations (1)

06510

Yale New Haven Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT04067609 - Postoperative Dexamethasone on Post-Cesarean Pain | Biotech Hunter | Biotech Hunter